Ibogaine By David Dardashti, a leading provider of ibogaine treatment for addiction, is excited to announce the opening of a new clinic in 2024 exclusively for those struggling with trauma and mental health issues. The clinic, located on the beautiful beaches of Cancun, will offer a unique and personalized approach to treating these often overlooked and stigmatized conditions.
The decision to open a clinic specifically for trauma and mental health treatment comes from the growing demand for alternative and effective solutions. With the rise in mental health issues and the lack of accessible and affordable treatment options, Ibogaine By David Dardashti saw the need for a specialized clinic that focuses solely on these conditions. The clinic will offer a holistic approach, combining traditional therapy with the use of ibogaine, a natural psychoactive substance known for its potential to alleviate trauma and mental health symptoms.
In addition to providing much-needed treatment, the new clinic also offers partnership opportunities for investors. This partnership will not only help expand the reach of the clinic but also contribute to the overall mission of providing quality care to those in need. The current clinic, which specializes in addiction treatment, will remain open and continue to provide its services.
Ibogaine By David Dardashti is committed to making a positive impact in the lives of individuals struggling with addiction, trauma, and mental health issues. The opening of the new clinic in Cancun is a significant step towards achieving this goal and providing much-needed care to those who need it the most. For more information about the clinic and partnership opportunities, please visit the website or contact the team directly.
DISCLAIMER:
This news release does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service. If any offer of securities is made, it will be pursuant to a definitive offering memorandum prepared by Ibogaine By David Dardashti that contains material information not contained herein and which supersedes this information in its entirety.
Neither KISS PR nor its distribution partners are responsible for any decisions made by readers or recipients based on the information provided in this press release. Readers and recipients are advised to contact the source company, in this case, Ibogaine By David Dardashti, for further information.
Remember, the information provided in this press release is about the source company. It does not provide advice on financial or other matters. It should not be construed to provide any kind of investment, medical, or other advice, and shouldn't be used in that way. Readers and recipients must decide for themselves what utility or benefit acting based on this information may offer them.
Readers and recipients are advised that decisions they make based on the information contained in this press release are their own responsibility and that they should contact a registered professional before making decisions.
For More Information Call Cole Baressi 1-800-818-4511 or [email protected] to request a information from David Dardashti
Release ID: 853450